# Award #75N93026D00017

Multi-year IDV Awarded to Research Triangle Institute for Antimicrobial Activity Assessment

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00017
**NAICS:** 541714

This indefinite delivery vehicle (IDV) contract was recently awarded to Research Triangle Institute, a research organization known for scientific and technological solutions, to conduct in vitro assessments of antimicrobial activity. The contract involves a comprehensive scientific evaluation aimed at advancing understanding and development of antimicrobial agents, which is critical for public health and pharmaceutical industries. As a multi-year agreement spanning a decade, it highlights the agency's commitment to long-term research in combating microbial threats. The work scope includes laboratory-based testing and analysis to determine the efficacy of antimicrobial substances. The contract was awarded through a non-competitive process, indicating a sole-source acquisition likely due to the specialized expertise of the recipient. While no contract vehicle or subcontractors are specified, this award supports ongoing efforts to enhance antimicrobial research capabilities and aligns with broader government health initiatives.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00017_7529)